Danaher Corporation revealed Tuesday it will purchase Masimo, a manufacturer of pulse oximeters, in a massive $9.9 billion deal. The acquisition aims to strengthen Danaher's medical diagnostics business portfolio.

Contract research corporation Danaher Corporation announced Tuesday its plans to purchase medical device manufacturer Masimo in a deal valued at $9.9 billion. The acquisition represents Danaher’s strategy to expand and strengthen its medical diagnostics business operations.
Masimo specializes in manufacturing pulse oximeters, devices commonly used in healthcare settings to measure oxygen levels in patients’ blood. The substantial purchase price reflects the growing importance of medical monitoring equipment in today’s healthcare landscape.
This major business transaction demonstrates Danaher’s commitment to growing its presence in the medical diagnostics sector through strategic acquisitions of established healthcare technology companies.
Ukrainian Forces Strike Russian Oil Terminal, Chemical Plant in Overnight Drone Attack
Italian Biathlete Cleared of Doping Charges Still Benched from Olympics
India Orders Major Tech Companies to Follow Constitution Under New Content Rules
Wall Street Stumbles Tuesday as AI Concerns Shake Investor Confidence